Clinical Trial Results The clinical trial SURMOUNT-5 (NCT05822830) of adults with obesity who did not have type 2 diabetes demonstrated that Zepbound patients had an average weight loss of 50.3 lbs (22.8 kg), which was 20.2% of their body weight, and a 7.2-inch ( 18.4 cm) reduction in waist circumference, at 72 weeks
It is important to treat any retatrutide available outside of a legitimate clinical trial with serious caution
Zepbound (tirzepatide) is a dual GLP-1/GIP receptor agonist primarily approved for chronic weight management, and also for type 2 diabetes (as Mounjaro), working by enhancing insulin secretion, slowing gastric emptying, and reducing appetite
Whether semaglutide expires after 28 days , whether tirzepatide expires , and how long semaglutide stays good are practical questions that affect the reliability of each dose
Who Should Consider the Wegovy Pill
[DOI] [PubMed] [Google Scholar] 70.Nadeem A., Ahmad S.F., Al-Harbi N.O., Attia S.M., Bakheet S.A., Ibrahim K.E., Alqahtani F., Alqinyah M
